[{"uuid": "55bdf12b-dde2-36ca-b551-18eb47f35073", "title": "Why Blueprint Medical (BPMC) Is Skyrocketing Now", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/why-blueprint-medical-bpmc-skyrocketing-080951651.html", "providerPublishTime": 1737878991, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/8GSZLiCWpXtSnHiot_BNpg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/31d05864e281d54d167de384e240b8ea", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/a9Aptl8.a.uamK8ViqDR7Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/31d05864e281d54d167de384e240b8ea", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BPMC"]}, {"uuid": "5269bff1-93d6-3ce2-8631-ed08a69c1284", "title": "Blueprint Medicines Insider Sold Shares Worth $1,660,511, According to a Recent SEC Filing", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/blueprint-medicines-insider-sold-shares-081209625.html", "providerPublishTime": 1737706329, "type": "STORY", "relatedTickers": ["BPMC"]}, {"uuid": "a5f7180e-5863-3c9d-b92b-eab218183ad5", "title": "Blueprint Stock Soars 18% on Encouraging 2025 Growth Strategy", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/blueprint-stock-soars-18-encouraging-151400664.html", "providerPublishTime": 1736867640, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/IYksUEF.ZX5JOPFmQ194jQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BPMC"]}, {"uuid": "e4ee8ed1-ebc3-3a22-a893-6eac15c87063", "title": "Blueprint Medicines (BPMC) Stock Jumps 18.2%: Will It Continue to Soar?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/blueprint-medicines-bpmc-stock-jumps-094300036.html", "providerPublishTime": 1736847780, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/apbC75v0joJeGGZArvqIvw--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c", "width": 900, "height": 675, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/QRZaVqotQ5qIVtJkA1fW4A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BPMC"]}, {"uuid": "410e1cfb-1653-3691-aa54-8abec83c0fb1", "title": "Zacks Industry Outlook Highlights Incyte, BioMarin, Exelixis, Halozyme and Blueprint Medicines", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/zacks-industry-outlook-highlights-incyte-084800976.html", "providerPublishTime": 1736930880, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/sb.6qRd7FfGt7.wCjWz2vw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/675c0ae70cb5036ad2ceb9062f13afc2", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/y6B.X5ymHvNNdOly.Nnp7w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/675c0ae70cb5036ad2ceb9062f13afc2", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BMRN", "INCY", "HALO", "EXEL", "^GSPC", "BPMC"]}, {"uuid": "eaaaeb89-4cf2-3b68-a524-bf95e98bc3da", "title": "Blueprint Medicines Expects Systemic Mastocytosis Franchise to Generate $4 Billion by 2030 -- Shares Up", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/blueprint-medicines-expects-systemic-mastocytosis-171238213.html", "providerPublishTime": 1736788358, "type": "STORY", "relatedTickers": ["BPMC"]}, {"uuid": "4fd8497f-c885-34ad-b902-2209153b3931", "title": "5 Biotech Stocks Worth Adding to Your Portfolio in 2025", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/5-biotech-stocks-worth-adding-150200564.html", "providerPublishTime": 1736866920, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/vtsVt8PEmb10KQ4cnwEJfQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/96776645e0ac7ab203b7d5e3b37251a6", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/B3sMsNX6Xfj2qd6ANCpM1Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/96776645e0ac7ab203b7d5e3b37251a6", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HALO", "BMRN", "EXEL", "INCY", "BPMC", "^GSPC"]}, {"uuid": "8d8600de-262b-3c9f-85c1-085ed8b664ad", "title": "Blueprint Medicines Surges Over 10% as 2025 Growth Strategy Ignites Investor", "publisher": "GuruFocus.com", "link": "https://finance.yahoo.com/news/blueprint-medicines-surges-over-10-161312584.html", "providerPublishTime": 1736784792, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/A96B6C20rjYdGvcHrygWlA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d5c90443f3d99a0d76c2ca0088116ddf", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/bw0QYKb8em4xyAIjQlSHCg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/d5c90443f3d99a0d76c2ca0088116ddf", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BPMC"]}, {"uuid": "b42b9127-67f8-31ba-b035-9f2c6a1c07ae", "title": "Blueprint Medicines Provides 2025 Outlook and Highlights Strategy for Continued Growth", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/blueprint-medicines-provides-2025-outlook-210000268.html", "providerPublishTime": 1736715600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/pKk3q4tmdinuwzkF3SutMA--~B/aD0xMzU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c740bc0c838c53d3519efe12ecb79940", "width": 400, "height": 135, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/c20lvAUhoEo0hlm_5NrCwQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/c740bc0c838c53d3519efe12ecb79940", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BPMC"]}, {"uuid": "da77218d-6da3-389f-aa83-278eaa1ac32d", "title": "High Growth Tech Stocks to Watch in January 2025", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/high-growth-tech-stocks-watch-140453530.html", "providerPublishTime": 1736345093, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/eZ0FiSKCVDYnTK6X1bRieQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BPMC", "PSTG", "NET"]}, {"uuid": "8b2dee42-7068-3d61-96ec-095c899e29bb", "title": "Blueprint Medicines (BPMC) Up 8.7% Since Last Earnings Report: Can It Continue?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/blueprint-medicines-bpmc-8-7-163146117.html", "providerPublishTime": 1732897906, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/hYDVEF34jJNULlluFRTwjg--~B/aD05MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4", "width": 900, "height": 900, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/SurBRNrCPD6U_NI2v5UP3A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BPMC"]}, {"uuid": "027db8cd-022f-3da8-a9eb-1cd60d1b35b5", "title": "Blueprint Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/blueprint-medicines-present-43rd-annual-130000549.html", "providerPublishTime": 1734526800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/pKk3q4tmdinuwzkF3SutMA--~B/aD0xMzU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c740bc0c838c53d3519efe12ecb79940", "width": 400, "height": 135, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/c20lvAUhoEo0hlm_5NrCwQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/c740bc0c838c53d3519efe12ecb79940", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BPMC"]}]